US 10576095
Use of aminoglycoside analogs in the treatment of Rett syndrome
granted A61KA61K31/7036A61P
Quick answer
US patent 10576095 (Use of aminoglycoside analogs in the treatment of Rett syndrome) held by ELOXX PHARMACEUTICALS LTD. expires Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ELOXX PHARMACEUTICALS LTD.
- Grant date
- Tue Mar 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/7036, A61P, A61P25/00, A61P43/00